From Phage Display to Nanoparticle Delivery: Functionalizing Liposomes with Multivalent Peptides Improves Targeting to a Cancer Biomarker

Bioconjugate Chemistry - Tập 24 Số 1 - Trang 85-96 - 2013
Bethany Powell Gray1, Shunzi Li2, Kathlynn C. Brown2
1Department of Internal Medicine and The Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-8807, United States
2Department of Internal Medicine and The Simmons Comprehensive#R#Cancer Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-8807,#R#United States

Tóm tắt

Từ khóa


Tài liệu tham khảo

Alley S. C., 2010, Curr. Opin. Chem. Biol., 14, 529, 10.1016/j.cbpa.2010.06.170

Reichert J. M., 2007, Nat. Rev. Drug Discovery, 6, 349, 10.1038/nrd2241

Bray B. L., 2003, Nat. Rev. Drug Discovery, 2, 587, 10.1038/nrd1133

Smith G. P., 1985, Science, 228, 1315, 10.1126/science.4001944

Smith G. P., 1997, Chem. Rev., 97, 391, 10.1021/cr960065d

Kehoe J. W., 2005, Chem. Rev., 105, 4056, 10.1021/cr000261r

Brown K. C., 2010, Curr. Pharm. Des., 16, 1040, 10.2174/138161210790963788

Aina O. H., 2007, Mol. Pharmaceutics, 4, 631, 10.1021/mp700073y

Barry M. A., 1996, Nat. Med., 2, 299, 10.1038/nm0396-299

Pasqualini R., 1996, Nature, 380, 364, 10.1038/380364a0

Mammen M., 1998, Angew. Chem., Int. Ed., 37, 2754, 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3

Kiessling L. L., 2000, Curr. Opin. Chem. Biol., 4, 696, 10.1016/S1367-5931(00)00153-8

Oyama T., 2003, Cancer Lett., 202, 219, 10.1016/j.canlet.2003.08.011

Helms B. A., 2009, J. Am. Chem. Soc., 131, 11683, 10.1021/ja902285m

Bastings M. M. C., 2011, J. Am. Chem. Soc., 133, 6636, 10.1021/ja110700x

De J., 2005, Mol. Biosyst., 1, 149, 10.1039/b504572j

McGuire M. J., 2004, DNA Cell Biol., 23, 742, 10.1089/dna.2004.23.742

McGuire M. J., 2006, Exp. Hematol., 34, 443, 10.1016/j.exphem.2005.12.013

Oyama T., 2006, Biosens. Bioelectron., 21, 1867, 10.1016/j.bios.2005.11.016

Li S., 2009, Mol. Cancer Ther., 8, 1239, 10.1158/1535-7163.MCT-08-1098

Loi M., 2010, J. Controlled Release, 145, 66, 10.1016/j.jconrel.2010.03.015

Lowery A., 2011, J. Controlled Release, 150, 117, 10.1016/j.jconrel.2010.11.006

Park J. H., 2010, Proc. Natl. Acad. Sci. U. S. A., 107, 981, 10.1073/pnas.0909565107

Akinc A., 2010, Mol. Ther., 18, 1357, 10.1038/mt.2010.85

Copland M. J., 2003, Vaccine, 21, 883, 10.1016/S0264-410X(02)00536-4

Espuelas S., 2003, Bioorg. Med. Chem. Lett., 13, 2557, 10.1016/S0960-894X(03)00472-4

Heurtault B., 2008, Pharm. Res., 26, 276, 10.1007/s11095-008-9724-y

Martin A. L., 2009, J. Am. Chem. Soc., 131, 734, 10.1021/ja807220u

Elayadi A. N., 2007, Cancer Res., 67, 5889, 10.1158/0008-5472.CAN-07-0245

Ahmed N., 2002, J. Histochem. Cytochem., 50, 1371, 10.1177/002215540205001010

Arihiro K., 2000, Breast Cancer, 7, 19, 10.1007/BF02967183

Bates R. C., 2005, J. Clin. Invest., 115, 339, 10.1172/JCI200523183

Hamidi S., 2000, Br. J. Cancer, 82, 1433, 10.1054/bjoc.1999.1130

Breuss J., 1995, J. Cell Sci., 108, 2241, 10.1242/jcs.108.6.2241

Kawashima A., 2003, Pathol. Res. Pract., 199, 57, 10.1078/0344-0338-00355

Hazelbag S., 2007, J. Pathol., 212, 316, 10.1002/path.2168

Hecht J. L., 2008, Appl. Immunohistochem. Mol. Morphol., 16, 543, 10.1097/PAI.0b013e31816bc5ee

Jones J., 1997, J. Oral Pathol. Med., 26, 63, 10.1111/j.1600-0714.1997.tb00023.x

Regezi J. A., 2002, Oral Oncol., 38, 332, 10.1016/S1368-8375(01)00062-8

Thomas G. J., 2006, J. Oral Pathol. Med., 35, 1, 10.1111/j.1600-0714.2005.00374.x

Prudkin L., 2009, Modern Pathol., 22, 668, 10.1038/modpathol.2009.19

Phelps R. M., 1996, J. Cell. Biochem., 63, 32, 10.1002/jcb.240630505

Shmeeda H., 2003, Methods Enzymology

Abraham S. A., 2005, The Liposomal Formulation of Doxorubicin, 391

Dubey P. K., 2004, J. Drug Targeting, 12, 257, 10.1080/10611860410001728040

Owens D. E., 2006, Int. J. Pharm., 307, 93, 10.1016/j.ijpharm.2005.10.010

Moore N. W., 2006, Biophys. J., 91, 1675, 10.1529/biophysj.105.079871